Cerecin strengthens position in neurometabolism with addition to pipeline
19 Sep 2023 //
PR NEWSWIRE
Cerecin to Present New Infantile Spasms Data at the 35th Epilepsy Congress, 2023
29 Aug 2023 //
PR NEWSWIRE
Cerecin appoints Marc Cantillon as CMO
10 Oct 2022 //
GLOBENEWSWIRE